Advantages |
· Patients are spared the effects of acute toxicity |
· Patients are spared the effects of serious late toxicity (i.e., myelodysplasia) |
· The development of shared "cross-resistance" to other therapies is avoided |
Disdvantages |
· Risk of severe complications associated with the disease during the interval between visits |
· The chances of obtaining a good antitumor response with the first course of treatment can decrease [16] |
· The risk of FL transformation into aggressive lymphoma can increase [23] |
· Anxiety caused by the fact of suffering an oncologic disease that is not being treated |